DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹16,747 Cr | ₹13,034 Cr | ₹9,588 Cr | ₹8,572 Cr | ₹9,766 Cr |
What is the latest Total Current Liabilities ratio of DR REDDYS LABORATORIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹16,747 Cr |
| Mar2025 | ₹13,034 Cr |
| Mar2024 | ₹9,588 Cr |
| Mar2023 | ₹8,572 Cr |
| Mar2022 | ₹9,766 Cr |
How is Total Current Liabilities of DR REDDYS LABORATORIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹16,747 Cr | 28.49 | |
| Mar2025 | ₹13,034 Cr | 35.94 | |
| Mar2024 | ₹9,588 Cr | 11.85 | |
| Mar2023 | ₹8,572 Cr | -12.22 | |
| Mar2022 | ₹9,766 Cr | - | |
Compare Total Current Liabilities of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹115,689.1 Cr | -0.1% | 16% | 14.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,073.0 Cr | 8.1% | 9.3% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹307,147.0 Cr | 10.5% | 18% | 51.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,626.0 Cr | 2.9% | 2.1% | 30.7% | Stock Analytics | |
| CIPLA | ₹113,589.0 Cr | 1.4% | 8.1% | -6.8% | Stock Analytics | |
| MANKIND PHARMA | ₹109,911.0 Cr | 4% | 7.5% | 5.8% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | -0.1% |
16% |
14.6% |
| SENSEX | 5.5% |
13.3% |
-3.4% |
You may also like the below Video Courses